Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm

Autores
Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.
Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados Unidos
Materia
AMINOGLUCOSIDOS
ACETILTRANSFERASA
RESISTENCIA ANTIBIOTICA
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/8396

id CONICETDig_3b7c00cd54e43c9bd4624386f60b8115
oai_identifier_str oai:ri.conicet.gov.ar:11336/8396
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigmRamirez, Maria SoledadNikolaidis, N.Tolmasky, M.AMINOGLUCOSIDOSACETILTRANSFERASARESISTENCIA ANTIBIOTICAhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados UnidosFil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados UnidosFil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados UnidosFrontiers2013-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/8396Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-131664-302Xenginfo:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2013.00121/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2013.00121info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656343/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:54Zoai:ri.conicet.gov.ar:11336/8396instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:54.699CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
title Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
spellingShingle Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
Ramirez, Maria Soledad
AMINOGLUCOSIDOS
ACETILTRANSFERASA
RESISTENCIA ANTIBIOTICA
title_short Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
title_full Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
title_fullStr Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
title_full_unstemmed Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
title_sort Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
dc.creator.none.fl_str_mv Ramirez, Maria Soledad
Nikolaidis, N.
Tolmasky, M.
author Ramirez, Maria Soledad
author_facet Ramirez, Maria Soledad
Nikolaidis, N.
Tolmasky, M.
author_role author
author2 Nikolaidis, N.
Tolmasky, M.
author2_role author
author
dc.subject.none.fl_str_mv AMINOGLUCOSIDOS
ACETILTRANSFERASA
RESISTENCIA ANTIBIOTICA
topic AMINOGLUCOSIDOS
ACETILTRANSFERASA
RESISTENCIA ANTIBIOTICA
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.
Fil: Ramirez, Maria Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones En Microbiología y Parasitología Médica; Argentina. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Nikolaidis, N.. California State University. College Of Natural Science And Mathematics; Estados Unidos
Fil: Tolmasky, M.. California State University. College Of Natural Science And Mathematics; Estados Unidos
description Enzymatic modification is a prevalent mechanism by which bacteria defeat the action of antibiotics. Aminoglycosides are often inactivated by aminoglycoside modifying enzymes encoded by genes present in the chromosome, plasmids, and other genetic elements. The AAC(6′)-Ib (aminoglycoside 6′-N-acetyltransferase type Ib) is an enzyme of clinical importance found in a wide variety of gram-negative pathogens. The AAC(6′)-Ib enzyme is of interest not only because of his ubiquity but also because of other characteristics, it presents significant microheterogeneity at the N-termini and the aac(6′)-Ib gene is often present in integrons, transposons, plasmids, genomic islands, and other genetic structures. Excluding the highly heterogeneous N-termini, there are 45 non-identical AAC(6′)-Ib related entries in the NCBI database, 32 of which have identical name in spite of not having identical amino acid sequence. While some variants conserved similar properties, others show dramatic differences in specificity, including the case of AAC(6′)-Ib-cr that mediates acetylation of ciprofloxacin representing a rare case where a resistance enzyme acquires the ability to utilize an antibiotic of a different class as substrate. Efforts to utilize antisense technologies to turn off expression of the gene or to identify enzymatic inhibitors to induce phenotypic conversion to susceptibility are under way.
publishDate 2013
dc.date.none.fl_str_mv 2013-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/8396
Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-13
1664-302X
url http://hdl.handle.net/11336/8396
identifier_str_mv Ramirez, Maria Soledad; Nikolaidis, N.; Tolmasky, M.; Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm; Frontiers; Frontiers in Microbiology; 4; 5-2013; 1-13
1664-302X
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2013.00121/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2013.00121
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656343/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers
publisher.none.fl_str_mv Frontiers
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269256007286784
score 13.13397